A.R.T. Advisors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

A.R.T. Advisors’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-106,114	Closed	-$488K	–	1890
2016 Q1	$488K	Sell	106,114 -105,500	-50%	-$424K	0.02%	869
2015 Q4	$1.1M	Sell	211,614 -72,840	-26%	-$423K	0.05%	519
2015 Q3	$1.72M	Buy	+284,454	New	+$3.49M	0.06%	424
2014 Q4	–	Sell	-121,261	Closed	-$1.16M	–	1926
2014 Q3	$1.16M	Buy	121,261 +103,796	+594%	+$1.06M	0.05%	465
2014 Q2	$201K	Sell	17,465 -31,615	-64%	-$288K	0.01%	1135
2014 Q1	$490K	Buy	49,080 +37,744	+333%	+$545K	0.03%	756
2013 Q4	$147K	Sell	11,336 -83,828	-88%	-$1.15M	0.01%	1156
2013 Q3	$1.42M	Buy	+95,164	New	+$1.14M	0.08%	384

Other funds holding RPTP

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

A.R.T. Advisors's RPTP Position: Q2 2016 in Review

A.R.T. Advisors sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2016, closing a stake of 106,114 shares — an estimated $488K sold.

A.R.T. Advisors first reported a position in RPTP in Q3 2013 and held it in 8 quarters. The position peaked at $1.72M in Q3 2015. 93 funds tracked by Wall St. Rank hold RPTP as of Q2 2016.

A.R.T. Advisors reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2016 after selling out during the quarter.
A.R.T. Advisors sold 106,114 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2016, an estimated $488K.
A.R.T. Advisors first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 8 quarters.
A.R.T. Advisors's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.72M in Q3 2015.
93 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2016.

Based on A.R.T. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.